Recent Finacing
Recent Raise
DiNAQOR develops gene therapies for inherited cardiomyopathies, advancing preclinical MYBPC3-targeting program DiNA-001 and collaborating with BioMarin to develop that and other pipeline programs.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at DiNAQOR.
